75 related articles for article (PubMed ID: 8261456)
1. Correspondence re: B. Fernandes et al., beta 1-6 branched oligosaccharides as a marker of tumor progression in human breast and colon neoplasia. Cancer Res., 51: 718-723, 1991.
Chammas R; Cella N; Marques LA; Brentani RR; Hynes NE; Franco EL
Cancer Res; 1994 Jan; 54(1):306-8. PubMed ID: 8261456
[No Abstract] [Full Text] [Related]
2. Beta 1-6 branched oligosaccharides as a marker of tumor progression in human breast and colon neoplasia.
Fernandes B; Sagman U; Auger M; Demetrio M; Dennis JW
Cancer Res; 1991 Jan; 51(2):718-23. PubMed ID: 1985789
[TBL] [Abstract][Full Text] [Related]
3. Beta1,6-branched oligosaccharides are increased in lymph node metastases and predict poor outcome in breast carcinoma.
Handerson T; Camp R; Harigopal M; Rimm D; Pawelek J
Clin Cancer Res; 2005 Apr; 11(8):2969-73. PubMed ID: 15837749
[TBL] [Abstract][Full Text] [Related]
4. Correspondence re: S. A. W. Fuqua et al., Estrogen receptor beta protein in human breast cancer: correlation with clinical tumor parameters. Cancer Res.,63: 2434-2439, 2003.
Speirs V
Cancer Res; 2003 Dec; 63(24):9055. PubMed ID: 14695225
[No Abstract] [Full Text] [Related]
5. [Relationship between the expression of E-cadherin-catenins and alpha-, beta-, gamma-catenin and the metastasis and prognosis of breast cancer].
Zou W; Hu CH; Zhou JP
Hunan Yi Ke Da Xue Xue Bao; 2002 Dec; 27(6):499-502. PubMed ID: 12658921
[TBL] [Abstract][Full Text] [Related]
6. Histologic markers and long-term prognosis in breast cancer.
Burtness BA
Cancer J Sci Am; 1997; 3(4):211-2. PubMed ID: 9263626
[No Abstract] [Full Text] [Related]
7. Correspondence re: S. Shimoyama et al., increased serum angiogenin concentration in colorectal cancer is correlated with cancer progression. Clin. Cancer Res., 5: 1125-1130, 1999.
Montero S; Lloveras B; Cortés-Funes H; Colomer R
Clin Cancer Res; 1999 Nov; 5(11):3722-3. PubMed ID: 10589792
[No Abstract] [Full Text] [Related]
8. Detection of occult metastatic breast cancer cells in blood by a multimolecular marker assay: correlation with clinical stage of disease.
Taback B; Chan AD; Kuo CT; Bostick PJ; Wang HJ; Giuliano AE; Hoon DS
Cancer Res; 2001 Dec; 61(24):8845-50. PubMed ID: 11751407
[TBL] [Abstract][Full Text] [Related]
9. Correspondence re: Somasundaram et al., Dietary curcumin inhibits chemotherapy-induced apoptosis in models of human breast cancer. Cancer Res., 62: 3868-3875, 2002.
Mitchell TM
Cancer Res; 2003 Aug; 63(16):5165-6; author reply 5166-7. PubMed ID: 12941849
[No Abstract] [Full Text] [Related]
10. Carcinoma-associated expression of core 2 beta-1,6-N-acetylglucosaminyltransferase gene in human colorectal cancer: role of O-glycans in tumor progression.
Shimodaira K; Nakayama J; Nakamura N; Hasebe O; Katsuyama T; Fukuda M
Cancer Res; 1997 Dec; 57(23):5201-6. PubMed ID: 9393734
[TBL] [Abstract][Full Text] [Related]
11. [Zymography--method for quantitation of activity on gelatinase A (pro-MMP-2, 72 kDa) and gelatinase B (pro-MMP-9, 92 kDa) in serum of patients with breast cancer].
Sliwowska I; Kopczyński Z
Wiad Lek; 2007; 60(5-6):241-7. PubMed ID: 17966888
[TBL] [Abstract][Full Text] [Related]
12. Re: Poremba et al Telomerase as a prognostic marker in breast cancer: high-throughput tissue microarray analysis of hTERT and hTR. J Pathol 2002; 198: 181-189.
Mokbel K; Newbold RF
J Pathol; 2003 Apr; 199(4):542. PubMed ID: 12635146
[No Abstract] [Full Text] [Related]
13. Beta1,6-branched oligosaccharides and coarse vesicles: a common, pervasive phenotype in melanoma and other human cancers.
Handerson T; Pawelek JM
Cancer Res; 2003 Sep; 63(17):5363-9. PubMed ID: 14500369
[TBL] [Abstract][Full Text] [Related]
14. Small beginnings: do they matter? The importance of lymphovascular invasion in early breast cancer.
Chivukula M; Brufsky A; Davidson NE
J Natl Cancer Inst; 2009 May; 101(10):698-9. PubMed ID: 19436037
[No Abstract] [Full Text] [Related]
15. Correspondence re: J. B. de Kok et al., DD3, A very sensitive and specific marker to detect prostate tumors. Cancer Res., 62: 2695-2698, 2002.
Gandini O; Santulli M; Cardillo MR; Stigliano A; Toscano V
Cancer Res; 2003 Aug; 63(15):4747; author reply 4748-9. PubMed ID: 12907658
[No Abstract] [Full Text] [Related]
16. Expression of sialyl lewis X, sialyl Lewis A, E-cadherin and cathepsin-D in human breast cancer: immunohistochemical analysis in mammary carcinoma in situ, invasive carcinomas and their lymph node metastasis.
Jeschke U; Mylonas I; Shabani N; Kunert-Keil C; Schindlbeck C; Gerber B; Friese K
Anticancer Res; 2005; 25(3A):1615-22. PubMed ID: 16033070
[TBL] [Abstract][Full Text] [Related]
17. [Occult multicentric breast cancer].
Vtorushin SV; Zab'ialova MV; Glushchenko SA; Perel'muter VM; Slonimskaia EM
Vopr Onkol; 2009; 55(1):38-41. PubMed ID: 19435197
[TBL] [Abstract][Full Text] [Related]
18. Commentary re: Q-T Le et al, identification of osteopontin as a prognostic marker for head and neck squamous cell carcinomas. clin cancer res, 9: 31-32, 2003.
Denhardt DT
Clin Cancer Res; 2003 Jan; 9(1):31-2. PubMed ID: 12538448
[No Abstract] [Full Text] [Related]
19. Inhibin/activin subunits (inhibin-alpha, -betaA and -betaB) are differentially expressed in human breast cancer and their metastasis.
Mylonas I; Jeschke U; Shabani N; Kuhn C; Friese K; Gerber B
Oncol Rep; 2005 Jan; 13(1):81-8. PubMed ID: 15583806
[TBL] [Abstract][Full Text] [Related]
20. Correspondence re: Samowitz et al., Microsatellite instability in sporadic colon cancer is associated with an improved prognosis at the population level. Cancer Epidemiol. Biomark. Prev., 10: 917-923, 2001.
Dolcetti R; Guidoboni M; Viel A; Boiocchi M
Cancer Epidemiol Biomarkers Prev; 2002 May; 11(5):499; author reply 499-500. PubMed ID: 12010867
[No Abstract] [Full Text] [Related]
[Next] [New Search]
